Latest News for: radium-223
Edit
CORRECTING and REPLACING New XOFIGO� (radium-223 dichloride) Data in Metastatic Castration-Resistant Prostate Cancer from Phase ...
Business Wire 31 May 2025
WHIPPANY, N.J.--(BUSINESS WIRE)--XOFIGO� (radium-223 dichloride) Data in Metastatic Castration-Resistant Prostate Cancer from Phase III PEACE III Trial Published in Annals of Oncology ... .
Edit
The Galveston Daily News
30 May 2025
CORRECTING and REPLACING New XOFIGO® (radium-223 dichloride) Data in Metastatic Castration-Resistant Prostate Cancer from Phase ...
The Galveston Daily News
30 May 2025
Edit
Hastings Tribune
30 May 2025
New XOFIGO® (radium-223 dichloride) Data in Metastatic Castration-Resistant Prostate Cancer from Phase III PEACE III ...
Hastings Tribune
30 May 2025
Edit
CORRECTING and REPLACING New XOFIGO® (radium-223 dichloride) Data in Metastatic Castration-Resistant Prostate Cancer from Phase III PEACE III Trial Published in Annals of Oncology (Bayer Corporation)
Public Technologies 30 May 2025
Edit
New XOFIGO® (radium-223 dichloride) Data in Metastatic Castration-Resistant Prostate Cancer from Phase III PEACE III Trial Published in Annals of Oncology (Bayer Corporation)
Public Technologies 30 May 2025
About Xofigo® (radium-223 dichloride) Injection2 ... Important Safety Information for Xofigo® (radium-223 dichloride) Injection ... Please see the full Prescribing Information for Xofigo (radium Ra 223 dichloride).
Edit
Cadillac News
28 May 2025
ASCO 2025: XOFIGO® (radium-223 dichloride) Combination Data Showcases Clinical Benefits in Metastatic Castration-Resistant Prostate Cancer ...
Cadillac News
28 May 2025
Edit
ASCO 2025: XOFIGO� (radium-223 dichloride) Combination Data Showcases Clinical Benefits in Metastatic Castration-Resistant Prostate Cancer ...
Business Wire 28 May 2025
WHIPPANY, N.J.--(BUSINESS WIRE)--ASCO 2025. XOFIGO� Combination Data Showcases Clinical Benefits in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases ... .
Edit
ASCO 2025: XOFIGO® (radium-223 dichloride) Combination Data Showcases Clinical Benefits in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases (Bayer Corporation)
Public Technologies 28 May 2025
About XOFIGO® (radium-223 dichloride) Injection1 ... Important Safety Information for Xofigo® (radium-223 dichloride) Injection ... Please see the full Prescribing Information for Xofigo (radium 223 dichloride).
- 1